The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tirabrutinib for the treatment of relapsed or refractory primary central nervous system lymphoma (R/R ...

Charles R. Goulding and Preeti Sulibhavi connect the hit TV drama’s emergency room realism to how Pittsburgh hospitals are already using 3D printing to plan surgeries and improve patient care.

Glaukos Corporation (NYSE:GKOS) Q4 2025 Earnings Call Transcript February 17, 2026 Glaukos Corporation misses on earnings ...

This special theme issue of NEJM Catalyst Innovations in Care Delivery, guest edited by Sara Murray, MD, MAS, includes articles, case studies, and research reports on the impacts of AI on clinical ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.

CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...

PARIS, FRANCE, 12 February 2026 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the full year (FY) 2025 and for the ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Rhythm Biosciences (ASX: RHY) has initiated the commercial deployment of its ColoSTAT test by enrolling the first physician ...

Insilico Medicine (“Insilico”, 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have released updated consensus guidelines and an associated reproducibility study to ...

Summit Therapeutics (NASDAQ:SMMT) is one of the best large cap stocks under $100 with huge upside potential. On January 14, H.C. Wainwright analyst Mitchell Kapoor reaffirmed his optimistic outlook on ...